{"database": "lobbying", "table": "lobbying_activities", "rows": [[2379447, "180fef8f-f01f-413a-8e8e-51f734458484", "Q4", "JAMES EDWARDS", 401027897, "CONSERVATIVES FOR PROPERTY RIGHTS", 2019, "fourth_quarter", "MMM", "Proposed International Pricing Index (IPI) payment model for drugs administered under Medicare Part B\nS. 377/H.R. 1046 (Medicare Negotiation and Competitive Licensing Act)\nReform of drug manufacturer rebates to third parties (e.g., pharmaceutical benefits managers, insurers)\nProposed binding arbitration for enacting government price controls under Medicare Part D\nInflationary penalty as government price controls in Medicare Part D\nS. 1129/H.R. 1384 (Medicare for All Act)\nSingle-payer health care\nH.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act) drug price controls through international reference pricing, direct federal price dictation, confiscatory penalty on the most innovative medicines", "Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR)", 10000, null, 0, 0, "2020-01-11T12:48:39.570000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2379447"], "units": {}, "query_ms": 0.7034589070826769, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}